Paper39196152
Atherosclerosis antigens as targets for immunotherapy.
Raposo-Gutiérrez I and 2 others. Nat Cardiovasc Res, 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Atherosclerosis antigens as targets for immunotherapy. Papers, record 39196152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39196152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| Adaptive Immunity | Major topic |
| Immunotherapy | Major topic |
| Humans | |
| Animals | |
| B-Lymphocytes | |
| Autoantigens | |
| T-Lymphocytes |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PID2019-106773RB-I00/AEI/10.13039/501100011033 | Ministerio de Economía, Industria y Competitividad, Gobierno de España (Ministerio de Economía, Industria y Competitividad) | PubMed | ||
| HR22-0253 | "la Caixa" Foundation (Caixa Foundation) | PubMed |
Source PubMed
References207
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33309175 | Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. | J Am Coll Cardiol | 2020 | https://conductscience.org/library/papers/33309175 | PubMed |
| 2 | 19302038 | Immune and inflammatory mechanisms of atherosclerosis (*). | Annu Rev Immunol | 2009 | https://conductscience.org/library/papers/19302038 | PubMed |
| 3 | 15843671 | Inflammation, atherosclerosis, and coronary artery disease. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15843671 | PubMed |
| 4 | 9887164 | Atherosclerosis--an inflammatory disease. | N Engl J Med | 1999 | https://conductscience.org/library/papers/9887164 | PubMed |
| 5 | 11239408 | Atherosclerosis. the road ahead. | Cell | 2001 | https://conductscience.org/library/papers/11239408 | PubMed |
| 6 | 2648148 | Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. | N Engl J Med | 1989 | https://conductscience.org/library/papers/2648148 | PubMed |
| 7 | 7667279 | Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7667279 | PubMed |
| 8 | 23995626 | Macrophages in atherosclerosis: a dynamic balance. | Nat Rev Immunol | 2013 | https://conductscience.org/library/papers/23995626 | PubMed |
| 9 | 28392564 | The immunology of atherosclerosis. | Nat Rev Nephrol | 2017 | https://conductscience.org/library/papers/28392564 | PubMed |
| 10 | 33883728 | The changing landscape of atherosclerosis. | Nature | 2021 | https://conductscience.org/library/papers/33883728 | PubMed |
| 11 | 34389841 | How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. | Nat Rev Immunol | 2022 | https://conductscience.org/library/papers/34389841 | PubMed |
| 12 | 29716940 | Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy. | Circulation | 2018 | https://conductscience.org/library/papers/29716940 | PubMed |
| 13 | 28845751 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28845751 | PubMed |
| 14 | 31733140 | Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31733140 | PubMed |
| 15 | 32865380 | Colchicine in Patients with Chronic Coronary Disease. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32865380 | PubMed |
| 16 | 11457878 | Lymphocytes are important in early atherosclerosis. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11457878 | PubMed |
| 17 | 11397712 | Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. | Arterioscler Thromb Vasc Biol | 2001 | https://conductscience.org/library/papers/11397712 | PubMed |
| 18 | 32340571 | In Vivo CD4+ T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm. | Annu Rev Immunol | 2020 | https://conductscience.org/library/papers/32340571 | PubMed |
| 19 | 32203286 | T cell subsets and functions in atherosclerosis. | Nat Rev Cardiol | 2020 | https://conductscience.org/library/papers/32203286 | PubMed |
| 20 | 16462800 | Natural regulatory T cells control the development of atherosclerosis in mice. | Nat Med | 2006 | https://conductscience.org/library/papers/16462800 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941217 | Deciphering Vascular Smooth Muscle Cell Phenotype Switching via Integrated Single-Cell Transcriptomics and Machine Learning: CX3CR1 and COL1A1 as Novel Diagnostic Biomarkers for Atherosclerosis. | Metabolites | 2026 | https://conductscience.org/library/papers/42941217 | PubMed |
| 42927614 | BDH1 Attenuates Macrophage Foam Cell Formation and Inflammation in Atherosclerosis Via Modulating Histone H3K9 Acylation Balance and Activating PPAR Signaling. | J Biochem Mol Toxicol | 2026 | https://conductscience.org/library/papers/42927614 | PubMed |
| 42905940 | NSG Mice Lacking Apoe: An Immunodeficient Mouse Model of Atherosclerosis. | FASEB J | 2026 | https://conductscience.org/library/papers/42905940 | PubMed |
| 42888064 | Taming inflammation in coronary artery disease: lessons learned, translational breakthroughs, and future directions. | Sci Bull (Beijing) | 2026 | https://conductscience.org/library/papers/42888064 | PubMed |
| 42839935 | Yiqihuoxue formula improves atherosclerosis by regulating macrophage polarization associated with enhanced STAT6/PPARγ pathway. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42839935 | PubMed |
| 42724038 | B cells and B-cell receptor repertoire features in coronary heart disease: immunopathogenic roles, clinical relevance, and therapeutic potential. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42724038 | PubMed |
| 42706439 | Artery tertiary lymphoid organs encode a pathogenic high-affinity autoantibody-autoantigen pair in atherosclerosis. | Nat Cardiovasc Res | 2026 | https://conductscience.org/library/papers/42706439 | PubMed |
| 42549668 | Nanomaterials-Based Immunotherapy for Atherosclerosis. | Small | 2026 | https://conductscience.org/library/papers/42549668 | PubMed |
| 42510870 | Integrated Bioinformatics and Machine Learning Analysis Identifies Inflammation-Related Biomarkers and Immune Infiltration Patterns in Atherosclerosis. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42510870 | PubMed |
| 42303606 | Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary disease. | Nat Commun | 2026 | https://conductscience.org/library/papers/42303606 | PubMed |
| 42112342 | Polymeric immunoglobulin receptor deficiency attenuates experimental atherosclerosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42112342 | PubMed |
| 42086715 | CD8+ T cells in atherosclerosis and coronary artery disease. | Nat Rev Cardiol | 2026 | https://conductscience.org/library/papers/42086715 | PubMed |
| 42001296 | T Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age-Related Diseases. | Immunol Rev | 2026 | https://conductscience.org/library/papers/42001296 | PubMed |
| 41494534 | Restoring immune homeostasis in atherosclerotic plaques via inorganic violet phosphorus nano-immunotherapy. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41494534 | PubMed |
| 41484095 | Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41484095 | PubMed |
| 40996881 | Tertiary Lymphoid Structures Across Organs: Context, Composition, and Clinical Levers. | Immunol Rev | 2025 | https://conductscience.org/library/papers/40996881 | PubMed |
| 40968356 | ALDH2 in autophagy and cell death: molecular mechanisms and implications for diseases. | Mil Med Res | 2025 | https://conductscience.org/library/papers/40968356 | PubMed |
| 40533521 | Loss of effector Treg signature in APOB-reactive CD4+ T cells in patients with coronary artery disease. | Nat Cardiovasc Res | 2025 | https://conductscience.org/library/papers/40533521 | PubMed |
| 40454002 | Mechanisms and implications of vascular-homing CD8 T cells in atherosclerosis. | NPJ Cardiovasc Health | 2025 | https://conductscience.org/library/papers/40454002 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39196152
GET https://conductscience.org/api/papers/v1/39196152/references?page=2